Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Inhaled Budesonide in Mild to Moderate COVID-19 Pneumonia
TCTR20220302001Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in coronavirus pneumonia, sponsored by Faculty of Medicine, Chiang Mai University. Started May 2021; status: recruiting.
02
Drugs
budesonide
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on TCTR20220302001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220302001.